376 related articles for article (PubMed ID: 19487302)
1. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
Adegbola MA
Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
[TBL] [Abstract][Full Text] [Related]
2. Genetic factors in pain and its treatment.
Stamer UM; Stüber F
Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601
[TBL] [Abstract][Full Text] [Related]
3. Understanding the genetic determinants of pain and pain management.
Miaskowski C
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the pharmacogenomics of pain and headache.
Montagna P
Neurol Sci; 2007 May; 28 Suppl 2():S208-12. PubMed ID: 17508172
[TBL] [Abstract][Full Text] [Related]
6. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects.
Kolesnikov Y; Gabovits B; Levin A; Voiko E; Veske A
Anesth Analg; 2011 Feb; 112(2):448-53. PubMed ID: 21127283
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics in pain management: the clinical need.
Webster LR
Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063
[TBL] [Abstract][Full Text] [Related]
8. Effect of genetic factors on opioid action.
Kosarac B; Fox AA; Collard CD
Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in obstetric anesthesia.
Landau R; Kraft JC
Curr Opin Anaesthesiol; 2010 Jun; 23(3):323-9. PubMed ID: 20440109
[TBL] [Abstract][Full Text] [Related]
10. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of morphine: Potential implications in sickle cell disease.
Darbari DS; Minniti CP; Rana S; van den Anker J
Am J Hematol; 2008 Mar; 83(3):233-6. PubMed ID: 17722074
[TBL] [Abstract][Full Text] [Related]
12. A primary care provider's guide to preventive and acute care management of adults and children with sickle cell disease.
Pack-Mabien A; Haynes J
J Am Acad Nurse Pract; 2009 May; 21(5):250-7. PubMed ID: 19432908
[TBL] [Abstract][Full Text] [Related]
13. [Genetic polymorphisms and opioid therapies].
Landau R
Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
[TBL] [Abstract][Full Text] [Related]
14. Current evidence for a genetic modulation of the response to analgesics.
Lötsch J; Geisslinger G
Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919
[No Abstract] [Full Text] [Related]
15. Modifier genes and sickle cell anemia.
Steinberg MH; Adewoye AH
Curr Opin Hematol; 2006 May; 13(3):131-6. PubMed ID: 16567954
[TBL] [Abstract][Full Text] [Related]
16. Genetic variability and clinical efficacy of morphine.
Klepstad P; Dale O; Skorpen F; Borchgrevink PC; Kaasa S
Acta Anaesthesiol Scand; 2005 Aug; 49(7):902-8. PubMed ID: 16045647
[TBL] [Abstract][Full Text] [Related]
17. Pain polymorphisms and opioids: An evidence based review.
Vieira CMP; Fragoso RM; Pereira D; Medeiros R
Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275
[TBL] [Abstract][Full Text] [Related]
18. Catecholamine-o-methyltransferase polymorphisms are associated with postoperative pain intensity.
Lee PJ; Delaney P; Keogh J; Sleeman D; Shorten GD
Clin J Pain; 2011 Feb; 27(2):93-101. PubMed ID: 20842020
[TBL] [Abstract][Full Text] [Related]
19. [Pain and genetics].
Møller AT; Kølvraa S; Jensen TS
Ugeskr Laeger; 2006 May; 168(20):1944-7. PubMed ID: 16768888
[TBL] [Abstract][Full Text] [Related]
20. Genetics of pain, opioids, and opioid responsiveness.
Tremblay J; Hamet P
Metabolism; 2010 Oct; 59 Suppl 1():S5-8. PubMed ID: 20837195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]